A retrospective cohort study revealed that nicotinamide exposure among adults did not increase the risk for major adverse cardiovascular events.

Some patients with atopic dermatitis who qualify for advanced systemic therapies do not receive them or may lack improvement with these therapies.

Clinicians should familiarize themselves with the risk factors and clinical identifiers of familial sex trafficking.

The outbreak of measles began earlier this year in Gaines County, Texas, and has since spread to New Mexico and now Oklahoma.

The Department of Health and Human Services has removed the 2024 surgeon general’s advisory on gun violence from its website.

The rescheduling of marijuana may remove regulatory hurdles and expand the breadth of research beyond pain management.

The rate of neonatal intensive care unit has increased in recent years to nearly 1 in 10 infants being admitted in 2023.

Apremilast improves disease severity and patient-reported outcomes among adults with psoriasis, regardless of genital involvement.

The total age-adjusted injury death rate among Americans was higher in 2023 than in 2013, reaching a peak in 2021.

Topline data were announced from pivotal phase 3 studies evaluating povorcitinib in adults with moderate to severe hidradenitis suppurativa.

Recreational use of nitrous oxide canisters like "Whip-it!" can cause temporary and lasting neurological damage.

Patients undergoing BRAF/MEK inhibitor therapy for melanoma more commonly experience VKH-like uveitis compared with other malignancy types.